Biological pathways and potential targets for prevention and therapy of chronic allograft nephropathy

Area of Science:

• Nephrology
• Transplantation Immunology
• Fibrosis Research

Background:

• Renal transplantation (RT) is the optimal treatment for end-stage renal disease, offering superior survival rates.
• Chronic allograft nephropathy (CAN) significantly limits graft half-life, leading to transplant failure and representing the primary cause of graft loss.
• Despite advancements in immunosuppression and patient care, CAN remains a critical unresolved challenge in RT.

Purpose of the Study:

• To conduct a comprehensive literature review on the pathogenesis of CAN.
• To elucidate the biological pathways involved in RT fibrogenesis.
• To identify and discuss potential therapeutic targets for CAN prevention and treatment.

Main Methods:

• Systematic review of existing literature.
• Analysis of studies focusing on fibrogenesis pathways in renal allografts.
• Identification of therapeutic strategies from published research.

Main Results:

• CAN pathogenesis involves complex molecular and cellular mechanisms leading to fibrosis.
• Key fibrotic pathways and mediators have been identified.
• Several potential therapeutic targets for mitigating CAN progression are emerging.

Conclusions:

• Understanding CAN pathogenesis is crucial for developing effective interventions.
• Targeting specific fibrotic pathways holds promise for improving long-term renal allograft survival.
• Further research is needed to translate these findings into clinical practice for CAN management.